Found 78 matching trials
XIENCE 28 USA Study NA The XIENCE 28 USA Study is prospective, single arm, multi-center, open labe...
Show More Location
Heart Center Research, LLC
Learn More & Join Trial
Comparison of the Supraflex Cruz 60 Micron Versus the Ultimaster Tansei 80 Micron in HBR PCI Population NA The study compares the outcome of the ultrathin stent strut Supraflex Cruz ...
Show More Location
Jeroen Bosch ziekenhuis
Learn More & Join Trial
Cruz HBR Registry - Post-market Registry to Evaluate the Safety and Efficacy of the Supraflex Cruz Stent N/A This is a prospective, multicenter, open-label, single-arm registry. The pr...
Show More Location
Centre Hospitalier Haguenau
Learn More & Join Trial
A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia PHASE2 The purpose of this study is to explore the safety and tolerability and the...
Show More Location
Multiple Locations
Learn More & Join Trial
EluNIR Ridaforolimus Eluting Coronary Stent System in Patients at High Bleeding Risk (HBR)- EluNIR HBR Study N/A The study will enroll approximately 316 subjects with a wide spectrum of PC...
Show More Learn More & Join Trial
A Relative Bioavailability Study of Citalopram HBr 10 mg Tablets Under Fasting Conditions PHASE1 The purpose of this study is compare the relative bioavailability of 10 mg ...
Show More Location
PRACS Institute, Ltd.
Learn More & Join Trial
Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy N/A Study Purpose Coronary heart disease (CAD) is a leading global cause of dea...
Show More Location
General Hospital of Northern Theater Command
Learn More & Join Trial
Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion PHASE3 This is a Phase 3, randomized, double-blind, placebo-controlled study evalu...
Show More Location
Santa Monica Clinical Trials
Learn More & Join Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients. NA XIENCE 90 study is a prospective, single arm, multi-center, open label tria...
Show More Location
Huntsville Hospital (Heart Center Research LLC)
Learn More & Join Trial
A Study to Characterize Single and Repeat Dose Pharmacokinetics of Tebipenem-Pivoxil-Hydrobromide (TBP-PI-HBr) and Its Major Metabolite (SPR1349) in Healthy Participants PHASE1 The main purpose of the study is to characterize the systemic pharmacokinet...
Show More Location
Medical Facility, Salt Lake City
Learn More & Join Trial